Case Study: Drug Dosage CS 170: Computing for the Sciences and Mathematics.

Slides:



Advertisements
Similar presentations
III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
Advertisements

Mathematical Investigations of Current Health Issues Theresa Laurent St. Louis College of Pharmacy 2007 AMATYC Conference.
© 2006 McGraw-Hill Higher Education. All rights reserved. Chapter 5 The Actions of Drugs.
Pharmacokinetics -- part 1 --
Plasmids Chromosome Plasmid Plasmid + Transposon Plasmid + integron Plasmid+transposon +intergron Chromosome Chromosome + transposon Chromosome + transposon.
Selected bioavailability and pharmacokinetic calculations Dr. Osama A. A. Ahmed.
Pharmacokinetics of Drug Absorption
One-compartment open model: Intravenous bolus administration
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
Using Drugs 2CoPE: Pharmacokinetics in Excel Gretchen A. Koch-Noble Department of Mathematics and Computer Science Goucher College BioQUEST Summer Workshop.
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Toxicokinetic Calculations
INTRAVENOUS INFUSION.
Objective: Explain the variation in dosing intervals for medications 1)Introduce Half-Life (t 1/2 ) 2)Relate Half-Life to Dosing intervals of aspirin and.
You have learned a LOT so far. A few extra facts to throw in No single reproducible abnormality in any NT, enzyme, receptor or gene has been found to.
Pharmacokinetics Introduction
Valproic Acid Software and Presentation by: Ted, Rob, Jeff, Cassie, Tristan, Korin, Ron, Gabe, Matt, Judith, Lindsay.
Infusions Mark Tomlin Consultant Pharmacist: Critical Care Southampton University Hospitals NHS Trust.
Drugs in the Body (1) Recurrence Relations A patient is given an initial dose of 50mg of a drug. Each hour the patient is given a 20mg tablet of the.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Modeling Interaction: Predator-Prey and Beyond CS 170: Computing for the Sciences and Mathematics.
One Compartment Open Model IV bolus
Core Concepts in Pharmacology Chapter 5 Pharmacokinetics.
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Calculation of Doses Prof. Dr. Henny Lucida, Apt.
Euler’s Method CS 170: Computing for the Sciences and Mathematics.
CS 170: Computing for the Sciences and Mathematics
PHARMACOKINETICS INTRODUCTION
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
Continuous intravenous infusion (one-compartment model)
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
BIOPHARMACEUTICS.
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
TDM Therapeutic Drug Monitoring
Constrained Growth CS 170: Computing for the Sciences and Mathematics.
Pharmacokinetics of Drug Absorption Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University.
Design of Sustained Release Dosage Forms
3.5 Drug Dosage. Single-Dose Model Modeling concentration of drug in system for a single dose is straightforward, using standard differential equation:
Clinical Pharmacokinetic Equations and Calculations
DEFINITIONS T1/2 & Tmax Cmax AUC 1st order kinetics
A Pharmacokinetic Drug Interaction Study of Drug-72 and Drug-12 Department of Mathematic & Statistics York University Yufeng Lin Xiaofeng Zhou.
How and Why Drugs Work Chapter 5. Intended and Unintended Effects of Drugs Intended responses: - Reason for using the drug Unintended responses: - Side.
415 PHT Plasma Level – Time Curve
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Pharmacokinetics 3rd Lecture
MULTIPLE DOSAGE REGIMEN
Drug Response Relationships
How and Why Drugs Work Chapter 5
Controls and Functions
Bioavailability of a drug from an immediate-release tablet containing 50 mg of drug given at 0, 4, and 8 hours compared to a single 150-mg drug dose given.
Biopharmaceutics of modified release drug products
Applications of Pharmacokinetics
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Quantitative Pharmacokinetics
Gretchen A. Koch Goucher College BioQUEST Summer 2007
Drug Therapy in Pediatric Patients
Biopharmaceutics Dr Mohammad Issa Saleh.
Pharmacokinetics Chapter 4
How and Why Drugs Work Chapter 5
Dose measurement Lecturer: dr. Asmaa abdelaziz Mohamed
How and Why Drugs Work Chapter 5
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Basic Biopharmaceutics
Therapeutic Drug Monitoring chapter 1 part 1
Principles and Methods of Drug Administration
Mathematics Unit 33: Drug Concentrations
Plasma concentration-time profile after oral administration of a single dose. Plasma concentration-time profile after oral administration of a single dose.
Presentation transcript:

Case Study: Drug Dosage CS 170: Computing for the Sciences and Mathematics

Administrivia Last time (in P265)  Constrained Growth Today  Case Study: Drug Dosage  HW3 Due  HW4 Assigned

Pharmacokinetics Scenario: Your company is developing a drug to help with something. You’ve been tasked with determining what the dosage instructions are going to be. What you know:  A little biology  Minimum effective (and Minimum toxic) drug concentrations  Half-life of the drug

One-Compartment Model of Single Dose Concentration of drug in system = amount of drug/volume of blood MEC = minimum effective concentration MTC = maximum therapeutic concentration or minimum toxic concentration

Example: Aspirin Blood in an adult's body ≈ 5 liters Amount of plasma ≈ 3 liters Two 325 mg tablets: 2(325)1000 µg Plasma half-life (t 1/2 ) of dose ~ 3.1 to 3.2 hr Q = aspirin_in_plasma dQ/dt = -KQ with K = -ln(0.5)/t 1/2 Therapeutic range  µg/ml Consider only a single dose

One-Compartment Model of Single Dose

Example: Dilantin Amount of plasma ≈ 3 liters One 100 mg tablet: 100,000 µg Plasma half-life (t 1/2 ) of dose ~ 22 hrs Q = dilantin_in_plasma dQ/dt = -KQ with K = -ln(0.5)/t 1/2 Therapeutic range  µg/ml  Toxicity only occurs at > 20,000 µg/ml Consider repeated doses. What is a good range?

One-Compartment Model of Repeated Doses ingested = absorption_fraction * (pulse of dosage over each interval)

Mathematics of Repeated Doses Absorption level ≈ 0.12 Elimination rate of –ln(0.5)/22 ≈ Amount of drug in the system after 8 hr is Q = Q 0 e (8) ≈ (12)(0.7772) = mg

Mathematics of Repeated Doses Q n - amount of drug in system immediately after dose n Q 1 = 12 mg Q 2 = 12(0.7772) + 12 Q 3 = Q 2 (0.7772) + 12 = 12(0.7772) (0.7772) + 12 Q n = Q n - 1 (0.7772) + 12 = 12(0.7772) n … + 12(0.7772) (0.7772) + 12

Finite geometric series a n … + a 2 + a 1 + a 0 = (1 - a n )/(1 - a) for a ≠ 1 Q n = 12(0.7772) n … + 12(0.7772) + 12 = 12( n )/( )  12(1)/( ) = mg

HOMEWORK! READ Module 3.5 in the textbook Homework 4  READ Module 7.4 in the textbook  COMPLETE Projects 1 and 2 (page 276)  Due next Monday, October 4 th